MD Atlas

Data last updated: Apr 2025

NEW WAVE LEFT TRIAL FEMUR S3

++M483L091104F9
On MarketClass IIa
RegulationEU MDR
Manufacturergroupe lépine
Primary DI+M483GNANW1430
ReferenceGNANW143
View on EUDAMED